MilliporeSigma Announces the Commemoration of Fifth Anniversary of M Lab™ Collaboration Center in Songdo, South Korea
News Release
- M Lab™ Collaboration Center marks five years of continuous operation, recording over 540 collaborations and trainings, benefitting over 1,000 biopharmaceutical and biotech customers
- Virtual open house will showcase the company’s bioprocessing capabilities to local university students
Burlington, Mass., October 21, 2021 – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Life Science business commemorated the fifth anniversary of its M Lab™ Collaboration Center in Songdo, South Korea. The M Lab™ Collaboration Center is a non-GMP facility, equipped and designed to recreate manufacturing environments, evaluate, and troubleshoot processes through hands-on and virtual trainings to support the needs of local and global industry experts.
“Since its establishment in 2016, our Songdo M Lab™ Collaboration Center has supported more than 100 biopharmaceutical and biotech customers including Samsung Biologics, Celltrion, and SK Bioscience,” said Yong Kim, Head of the company’s Process Solutions business in Korea. “The biopharmaceutical industry in South Korea is growing exponentially with a strong emphasis on new drug development. Through our M Lab™ Collaboration Center, we provide technical expertise, as well as customizable solutions in process development, from early stage to industrial production, which helps our life science customers accelerate therapies to market faster and safer.”
In conjunction with the fifth-anniversary celebration, the Life Science business sector in Korea has organized a virtual open house on November 4 for local university students. The program includes a virtual walk-through of the lab, showcasing its bioprocessing capabilities, from upstream to downstream and through final fill.
The Songdo M Lab™ Collaboration Center is one of the Life Science business sector’s nine centers worldwide. Since 2016, the lab has held more than 540 trainings, comprising hands-on knowledge transfer as well as annual training courses focused on Automatic Filter Integrity Testing and Operation of Tangential Flow Filtration.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.
Pour continuer à lire, veuillez vous connecter à votre compte ou en créer un.
Vous n'avez pas de compte ?